메뉴 건너뛰기




Volumn 3, Issue 8, 2013, Pages

A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; CANCER DIAGNOSIS; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LETTER; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA;

EID: 84883001834     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.33     Document Type: Letter
Times cited : (20)

References (8)
  • 1
    • 0036839014 scopus 로고    scopus 로고
    • Flow cytometric disease monitoring in multiple myeloma: The relationship between normal and neoplastic plasma cells predicts outcome after transplantation
    • DOI 10.1182/blood-2001-12-0297
    • Rawstron AC, Davies FE, Das Gupta R, Ashcroft AJ, Patmore R, Drayson MT et al. Flow cytometric disease monitoring in multiple myeloma: The relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 2002; 100: 3095-3100 (Pubitemid 35217054)
    • (2002) Blood , vol.100 , Issue.9 , pp. 3095-3100
    • Rawstron, A.C.1    Davies, F.E.2    Dasgupta, R.3    John Ashcroft, A.4    Patmore, R.5    Drayson, M.T.6    Owen, R.G.7    Jack, A.S.8    Anthony Child, J.9    Morgan, G.J.10
  • 2
    • 0026071476 scopus 로고
    • Expression of the neural cell adhesion molecule (CD56) by human myeloma cells
    • Drach J, Gattringer C, Huber H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol 1991; 83: 418-422
    • (1991) Clin Exp Immunol , vol.83 , pp. 418-422
    • Drach, J.1    Gattringer, C.2    Huber, H.3
  • 4
    • 27644571177 scopus 로고    scopus 로고
    • CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target [14]
    • DOI 10.1038/sj.leu.2403948, PII 2403948
    • Robillard N, Wuillème S, Lodé L, Magrangeas F, Minvielle S, Avet-Loiseau H. CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target. Leukemia 2005; 19: 2021-2022 (Pubitemid 41554021)
    • (2005) Leukemia , vol.19 , Issue.11 , pp. 2021-2022
    • Robillard, N.1    Wuilleme, S.2    Lode, L.3    Magrangeas, F.4    Minvielle, S.5    Avet-Loiseau, H.6
  • 7
    • 34548141773 scopus 로고    scopus 로고
    • A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma [2]
    • DOI 10.1038/sj.leu.2404815, PII 2404815
    • Tute RM, Jack AS, Child JA, Morgan GJ, Owen RG, Rawstron AC. A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma. Leukemia 2007; 21: 2046-2049 (Pubitemid 47299981)
    • (2007) Leukemia , vol.21 , Issue.9 , pp. 2046-2049
    • De Tute, R.M.1    Jack, A.S.2    Child, J.A.3    Morgan, G.J.4    Owen, R.G.5    Rawstron, A.C.6
  • 8
    • 80051878656 scopus 로고    scopus 로고
    • Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors
    • Peceliunas V, Janiulioniene A, Matuzeviciene R, Griskevicius L. Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors. Cytometry B Clin Cytom 2011; 80: 318-323
    • (2011) Cytometry B Clin Cytom , vol.80 , pp. 318-323
    • Peceliunas, V.1    Janiulioniene, A.2    Matuzeviciene, R.3    Griskevicius, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.